Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 12:03 pm Purchase |
2024-02-09 | 13G | Fidelity Quality Factor ETF FQAL |
FMR LLC | 2,367,343 21.327% |
1,600,545 (+208.73%) |
Filing History |
| 2024-02-12 12:03 pm Purchase |
2024-02-09 | 13G | iShares California Muni Bond ETF CMF |
FMR LLC | 4,773,762 10.103% |
137,066 (+2.96%) |
Filing History |
| 2024-02-12 12:03 pm Purchase |
2024-02-09 | 13G | Ciena Corporation CIEN |
FMR LLC | 14,726,348 10.155% |
3,408,694 (+30.12%) |
Filing History |
| 2024-02-12 12:03 pm Sale |
2024-02-09 | 13G | Karuna Therapeutics, Inc. KRTX |
FMR LLC | 858,944 2.276% |
-2,007,050 (-70.03%) |
Filing History |
| 2024-02-12 12:03 pm Sale |
2024-02-09 | 13G | Fidelity Low Volatility Factor ETF FDLO |
FMR LLC | 8,359,894 43.428% |
-2,297,373 (-21.56%) |
Filing History |
| 2024-02-12 12:03 pm Sale |
2024-02-09 | 13G | Orchard Therapeutics plc ORTX |
FMR LLC | 0 0.000% |
-8,611,360 (Position Closed) |
Filing |
| 2024-02-12 12:03 pm Purchase |
2024-02-09 | 13G | Spyre Therapeutics, Inc. SYRE |
FMR LLC | 6,206,451 13.065% |
2,420,574 (+63.94%) |
Filing History |
| 2024-02-09 10:21 am Purchase |
2024-02-08 | 13G | iShares MSCI EAFE Min Vol Factor ETF EFAV |
FMR LLC | 13,784,614 12.931% |
1,466,883 (+11.91%) |
Filing History |
| 2024-02-09 10:21 am Sale |
2024-02-08 | 13G | iShares Russell 1000 ETF IWB |
FMR LLC | 10,442,799 8.408% |
-1,693,508 (-13.95%) |
Filing History |
| 2024-02-09 10:21 am Sale |
2024-02-08 | 13G | iShares MSCI USA Momentum Factor ETF MTUM |
FMR LLC | 571,035 1.066% |
-3,696,868 (-86.62%) |
Filing History |
| 2024-02-09 10:20 am Sale |
2024-02-08 | 13G | iShares S&P Mid-Cap 400 Value ETF IJJ |
FMR LLC | 3,428,206 5.315% |
-306,254 (-8.20%) |
Filing History |
| 2024-02-09 10:20 am Purchase |
2024-02-08 | 13G | Spyre Therapeutics, Inc. SYRE |
FMR LLC | 3,785,877 7.969% |
3,785,877 (New Position) |
Filing History |
| 2024-02-09 10:20 am Sale |
2024-02-08 | 13G | iShares U.S. Treasury Bond ETF GOVT |
FMR LLC | 56,602,866 5.754% |
-17,617,885 (-23.74%) |
Filing History |
| 2024-02-09 10:20 am Sale |
2024-02-08 | 13G | iShares MSCI United Kingdom ETF EWU |
FMR LLC | 2,905 0.003% |
-6,597,360 (-99.96%) |
Filing History |
| 2024-02-09 10:20 am Sale |
2024-02-08 | 13G | PacWest Bancorp PACW |
FMR LLC | 0 0.000% |
-10,590,953 (Position Closed) |
Filing History |
| 2024-02-09 10:20 am Sale |
2024-02-08 | 13G | iShares National Muni Bond ETF MUB |
FMR LLC | 18,878,537 5.364% |
-10,625,196 (-36.01%) |
Filing History |
| 2024-02-09 10:20 am Purchase |
2024-02-08 | 13G | iShares MSCI Australia ETF EWA |
FMR LLC | 10,733,059 12.169% |
2,888,294 (+36.82%) |
Filing History |
| 2024-02-09 10:20 am Purchase |
2024-02-08 | 13G | iShares International Treasury Bond ETF IGOV |
FMR LLC | 79,330 8.627% |
79,330 (New Position) |
Filing History |
| 2024-02-09 10:20 am Purchase |
2024-02-08 | 13G | iShares MSCI USA Quality Factor ETF QUAL |
FMR LLC | 15,328,938 6.249% |
2,758,760 (+21.95%) |
Filing History |
| 2024-02-09 10:20 am Purchase |
2024-02-08 | 13G | iShares MSCI USA Min Vol Factor ETF USMV |
FMR LLC | 20,621,987 6.033% |
20,621,987 (New Position) |
Filing History |